Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Chappie

Showing results (1-10 of 18) with videos related to

Pageof 2
Sort By:
Healthcare Informatics : the Business Magazine for Information and Communication Systems|July 7, 1995
Streamlining lab services: point-of-care technologyP Winner, A Chappie
Journal of Medicinal Chemistry|July 28, 2012
Current landscape of phosphodiesterase 10A (PDE10A) inhibitionThomas A Chappie, Christopher J Helal, Xinjun Hou
Frontiers in Neuroscience|February 8, 2021
PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action?Frank S Menniti, Thomas A Chappie, Christopher J Schmidt
Current Opinion in Investigational Drugs (London, England : 2000)|February 1, 2007
Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophreniaFrank S Menniti, Thomas A Chappie, John M Humphrey, et al.
ACS Chemical Biology|October 9, 2014
Chemoproteomics demonstrates target engagement and exquisite selectivity of the clinical phosphodiesterase 10A inhibitor MP-10 in its native environmentJan-Philip Schülke, Laura A McAllister, Kieran F Geoghegan, et al.
The Journal of Organic Chemistry|May 16, 2009
Diastereoselective synthesis of 2,3,6-trisubstituted piperidinesJohn M Humphrey, Eric P Arnold, Thomas A Chappie, et al.
ACS Medicinal Chemistry Letters|January 21, 2022
Discovery of Small-Molecule CD33 Pre-mRNA Splicing ModulatorsThomas A Chappie, Mario Abdelmessih, Claude W Ambroise, et al.
Journal of Medicinal Chemistry|May 3, 2018
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1John M Humphrey, Matthew Movsesian, Christopher W Am Ende, et al.
Journal of Medicinal Chemistry|January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitorsThomas A Chappie, John M Humphrey, Martin P Allen, et al.
Journal of Medicinal Chemistry|May 9, 2013
Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligandLei Zhang, Anabella Villalobos, Elizabeth M Beck, et al.
Pageof 2

Showing results (1-10 of 18) with videos related to

Sort By:
Pageof 2
Healthcare Informatics : the Business Magazine for Information and Communication Systems|July 7, 1995
Streamlining lab services: point-of-care technologyP Winner, A Chappie
Journal of Medicinal Chemistry|July 28, 2012
Current landscape of phosphodiesterase 10A (PDE10A) inhibitionThomas A Chappie, Christopher J Helal, Xinjun Hou
Frontiers in Neuroscience|February 8, 2021
PDE10A Inhibitors-Clinical Failure or Window Into Antipsychotic Drug Action?Frank S Menniti, Thomas A Chappie, Christopher J Schmidt
Current Opinion in Investigational Drugs (London, England : 2000)|February 1, 2007
Phosphodiesterase 10A inhibitors: a novel approach to the treatment of the symptoms of schizophreniaFrank S Menniti, Thomas A Chappie, John M Humphrey, et al.
ACS Chemical Biology|October 9, 2014
Chemoproteomics demonstrates target engagement and exquisite selectivity of the clinical phosphodiesterase 10A inhibitor MP-10 in its native environmentJan-Philip Schülke, Laura A McAllister, Kieran F Geoghegan, et al.
The Journal of Organic Chemistry|May 16, 2009
Diastereoselective synthesis of 2,3,6-trisubstituted piperidinesJohn M Humphrey, Eric P Arnold, Thomas A Chappie, et al.
ACS Medicinal Chemistry Letters|January 21, 2022
Discovery of Small-Molecule CD33 Pre-mRNA Splicing ModulatorsThomas A Chappie, Mario Abdelmessih, Claude W Ambroise, et al.
Journal of Medicinal Chemistry|May 3, 2018
Discovery of Potent and Selective Periphery-Restricted Quinazoline Inhibitors of the Cyclic Nucleotide Phosphodiesterase PDE1John M Humphrey, Matthew Movsesian, Christopher W Am Ende, et al.
Journal of Medicinal Chemistry|January 19, 2007
Discovery of a series of 6,7-dimethoxy-4-pyrrolidylquinazoline PDE10A inhibitorsThomas A Chappie, John M Humphrey, Martin P Allen, et al.
Journal of Medicinal Chemistry|May 9, 2013
Design and selection parameters to accelerate the discovery of novel central nervous system positron emission tomography (PET) ligands and their application in the development of a novel phosphodiesterase 2A PET ligandLei Zhang, Anabella Villalobos, Elizabeth M Beck, et al.
Pageof 2